ArticleOncotarget2017

LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.

Qiong-Ni Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.